Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (FY)Apr 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets | |||||||||
| Cash, cash equivalents and short term investments | 83.87%5.48M | --5.99M | 110.47%6.43M | 110.47%6.43M | --2.95M | --2.98M | 25.63%3.06M | --3.06M | --2.43M |
| -Cash and cash equivalents | 83.87%5.48M | --5.99M | 110.47%6.43M | 110.47%6.43M | --2.95M | --2.98M | 25.63%3.06M | --3.06M | --2.43M |
| Receivables | --141.13K | --137.61K | 1,254.63%126.36K | 1,254.63%126.36K | ---- | ---- | --9.33K | --9.33K | ---- |
| -Accounts receivable | --141.13K | --137.61K | 1,254.63%126.36K | 1,254.63%126.36K | ---- | ---- | --9.33K | --9.33K | ---- |
| Prepaid assets | --5.6K | --8.32K | --18.44K | --18.44K | ---- | ---- | --0 | --0 | ---- |
| Other current assets | ---- | ---- | ---- | ---- | --69.88K | --41.25K | 95.93%9.33K | --9.33K | --4.76K |
| Total current assets | 86.21%5.63M | --6.14M | 114.56%6.58M | 114.56%6.58M | --3.02M | --3.02M | 25.76%3.07M | --3.07M | --2.44M |
| Non current assets | |||||||||
| Net PPE | 116.50%985.09K | --985.09K | 99.90%909.53K | 99.90%909.53K | --855K | --455K | 30.00%455K | --455K | --350K |
| Total non current assets | 116.50%985.09K | --985.09K | 99.90%909.53K | 99.90%909.53K | --855K | --455K | 30.00%455K | --455K | --350K |
| Total assets | 90.17%6.62M | --7.12M | 112.66%7.49M | 112.66%7.49M | --3.87M | --3.48M | 26.30%3.52M | --3.52M | --2.79M |
| Liabilities | |||||||||
| Current liabilities | |||||||||
| Current liabilities | 1,138.67%1.38M | --1.33M | 2,346.27%1.52M | 2,346.27%1.52M | --365.03K | --111.51K | -77.51%62.33K | --62.33K | --277.12K |
| Non current liabilities | |||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | 1,138.67%1.38M | --1.33M | 2,346.27%1.52M | 2,346.27%1.52M | --365.03K | --111.51K | -77.51%62.33K | --62.33K | --277.12K |
| Shareholders'equity | |||||||||
| Share capital | 110.39%9.86M | --9.86M | 118.00%9.86M | 118.00%9.86M | --5.09M | --4.69M | 54.33%4.52M | --4.52M | --2.93M |
| -common stock | 110.39%9.86M | --9.86M | 118.00%9.86M | 118.00%9.86M | --5.09M | --4.69M | 54.33%4.52M | --4.52M | --2.93M |
| Additional paid-in capital | 58.63%2.01M | --2.01M | 63.30%2.01M | 63.30%2.01M | --1.27M | --1.27M | -11.59%1.23M | --1.23M | --1.39M |
| Retained earnings | -148.00%-6.64M | ---6.09M | -167.65%-5.91M | -167.65%-5.91M | ---2.98M | ---2.68M | -39.88%-2.21M | ---2.21M | ---1.58M |
| Other equity interest | ---- | ---- | ---- | ---- | --136.36K | --88.34K | 62.21%-89.27K | ---89.27K | ---236.25K |
| Total stockholders'equity | 55.45%5.23M | --5.79M | 72.40%5.96M | 72.40%5.96M | --3.51M | --3.37M | 37.75%3.46M | --3.46M | --2.51M |
| Total equity | 55.45%5.23M | --5.79M | 72.40%5.96M | 72.40%5.96M | --3.51M | --3.37M | 37.75%3.46M | --3.46M | --2.51M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.